BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
Amniowrap2„¢ Product Launch Leads Year of Highlights for BioStem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors